These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 30904896)
61. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. Little RF; Aleman K; Kumar P; Wyvill KM; Pluda JM; Read-Connole E; Wang V; Pittaluga S; Catanzaro AT; Steinberg SM; Yarchoan R Blood; 2007 Dec; 110(13):4165-71. PubMed ID: 17846226 [TBL] [Abstract][Full Text] [Related]
62. In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicin. Lucia MB; Rutella S; Leone G; Larocca LM; Vella S; Cauda R J Acquir Immune Defic Syndr; 2002 Aug; 30(4):369-78. PubMed ID: 12138343 [TBL] [Abstract][Full Text] [Related]
63. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy. Leitch H; Trudeau M; Routy JP HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778 [TBL] [Abstract][Full Text] [Related]
64. The response of HIV-associated lymphadenopathic Kaposi sarcoma to highly active antiretroviral therapy evaluated by 18F-FDG PET/CT. Mankia SK; Miller RF; Edwards SG; Ramsay A; Lee SM Clin Nucl Med; 2012 Jul; 37(7):692-3. PubMed ID: 22691516 [TBL] [Abstract][Full Text] [Related]
65. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma. Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906 [TBL] [Abstract][Full Text] [Related]
66. Facing up to the ongoing challenge of Kaposi's sarcoma. Robey RC; Bower M Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104 [TBL] [Abstract][Full Text] [Related]
67. Isolated intraparotid Kaposi sarcoma in human immunodeficiency virus type 1 infection. Rizos E; Drosos AA; Ioannidis JP Mayo Clin Proc; 2003 Dec; 78(12):1561-3. PubMed ID: 14661687 [TBL] [Abstract][Full Text] [Related]
68. Chylothorax in a patient with AIDS and Kaposi's sarcoma. Judson MA; Postic B South Med J; 1990 Mar; 83(3):322-4. PubMed ID: 2315779 [TBL] [Abstract][Full Text] [Related]
69. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. Bower M; Nelson M; Young AM; Thirlwell C; Newsom-Davis T; Mandalia S; Dhillon T; Holmes P; Gazzard BG; Stebbing J J Clin Oncol; 2005 Aug; 23(22):5224-8. PubMed ID: 16051964 [TBL] [Abstract][Full Text] [Related]
70. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672 [TBL] [Abstract][Full Text] [Related]
71. Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS. Salto JN; Volkow P; Herrera-Goepfert R; López-Garcia AI; Cortes-Garcia BY; García-Pérez FO; Arroyo-Hernandez M; Rivera-Rosales RM AIDS; 2024 May; 38(6):933-934. PubMed ID: 38578965 [No Abstract] [Full Text] [Related]
72. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin. Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313 [TBL] [Abstract][Full Text] [Related]